If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.34
Bid: 42.10
Ask: 42.16
Change: 0.04 (0.09%)
Spread: 0.06 (0.143%)
Open: 41.40
High: 42.54
Low: 41.40
Prev. Close: 42.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Oct 2019 07:00

RNS Number : 5770O
Assura PLC
03 October 2019
 

3 October 2019

Assura plc

 

Trading Update

For the first half of the year to 30 September 2019

 

Assura's high-quality portfolio further enhanced; GPI acquisition successfully integrated

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first half of the year to 30 September 2019.

 

Jonathan Murphy, CEO, said:

"Assura has had a very active first six months of the reporting year as we continue to build on our strong progress. The acquisition of GPI, announced in May this year, has been integrated into Assura successfully, and further strengthens our market-leading position, putting us in a better place to provide GPs with the real estate that they need to help alleviate the stresses in the NHS.

 

"We remain confident in our outlook for the year and look forward to sharing a fuller update at our interim results in November."

 

Continued improvement to strong portfolio, supported by GPI acquisition

·; Current portfolio of 560 properties.

·; Two developments completed (Darley Dale & South Woodham Ferrers) at a cost of £8.4 million and five moved to on site (Canterbury, St Leonards, Hereford, Launceston and Bournville); total of 14 developments on site at the period end with a total development cost of £69 million.

·; Nine acquisitions completed in the period at a cost of £34.3 million.

·; 14 disposals completed for £18 million cash consideration at a small premium to book value at March 2019.

 

Strong development pipeline offers significant opportunity

·; Immediate development pipeline of £72 million.

·; Immediate acquisitions pipeline of £65 million, compared with £41 million at March 2019.

·; Total immediate pipeline, including on site developments, worth £206 million, up from £142 million at year end.

 

Continued rent roll growth

·; 13 lease re-gears agreed on £0.9 million of rent, adding weighted average of 8.5 years WAULT to those leases.

·; Annualised rent roll at £104.4 million taking account of additions, disposals and rent reviews.

 

Strong financials provide solid platform as the group continues to grow

·; Issued £107 million of privately placed notes announced on 8 August 2019 in two series (10 and 15 years' maturities) with a weighted average interest rate of 2.3%.

·; As at 30 September 2019 gross debt stood at £757 million with undrawn facilities of £250 million.

 

Results for the six months ended 30 September 2019 will be announced on 12 November 2019.

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFEEIILFIIA
Date   Source Headline
11th Feb 20144:48 pmRNSNotification of Major Interest in Shares
29th Jan 20144:39 pmRNSNotification of Vesting of Share Award to PDMR
24th Jan 201410:17 amRNSDirector/PDMR Shareholding
24th Jan 20147:00 amRNSSale of LIFT Investments
2nd Jan 20144:15 pmRNSDirector/PDMR Shareholding
20th Dec 201310:46 amRNSConfirmation of Quarterly Interim Dividend
12th Dec 20131:17 pmRNSNotification of major interest in shares
11th Dec 20133:23 pmRNSNotification of major interest in shares
10th Dec 20133:45 pmRNSNotification of major interest in shares
9th Dec 20133:52 pmRNSNotification of major interest in shares
9th Dec 20133:01 pmRNSNotification of major interest in shares
3rd Dec 20134:22 pmRNSDirector/PDMR Shareholding
3rd Dec 201310:18 amRNSNotification of major interest in shares
27th Nov 20131:03 pmRNSDirector/PDMR Shareholding
27th Nov 20131:01 pmRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSInterim Results 2013
25th Nov 20137:00 amRNSSale of LIFT Investments
5th Nov 20133:43 pmRNSDirector Declaration
5th Nov 20131:23 pmRNSNotification of Major Interests in Shares
14th Oct 20131:31 pmRNSNotifications of Major Interests in Shares
3rd Oct 20137:00 amRNSConfirmation of Quarterly Interim Dividend
19th Sep 20131:33 pmRNSResults of AGM
11th Sep 20137:00 amRNSAcquisition of 32 medical centres for £62.5m
20th Aug 20134:35 pmRNSHolding(s) in Company
16th Aug 20137:00 amRNSAppointment of Joint Corporate Broker
12th Aug 20137:00 amRNSInterim Management Statement
24th Jul 201310:25 amRNSAnnual Information Update
22nd Jul 20134:04 pmRNSAnnual Report 2013
17th Jun 201310:05 amRNSConfirmation of Quarterly Interim Dividend
29th May 201311:42 amRNSForm 8.5 (EPT/NON-RI)
29th May 201310:54 amRNSForm 8.5 (EPT/NON-RI)
29th May 20139:46 amRNSForm 8.5 (EPT/NON-RI)
29th May 20139:38 amRNSForm 8.5 (EPT/RI)
28th May 20135:15 pmRNSOffer Update
28th May 20131:51 pmRNSForm 8.3 - Assura Group Ltd
28th May 201312:27 pmRNSRejection of MedicX Proposal
28th May 201312:26 pmRNSUnaudited Preliminary Results to 31 March 2013
28th May 201311:04 amRNSForm 8.5 (EPT/NON-RI)
28th May 201310:04 amRNSForm 8.5 (EPT/NON-RI)
28th May 20137:54 amRNSForm 8.5 (EPT/RI)
24th May 20139:31 amRNSForm 8.5 (EPT/NON-RI)
24th May 20138:48 amRNSForm 8.5 (EPT/NON-RI)
24th May 20138:11 amRNSForm 8.5 (EPT/RI)
23rd May 20133:30 pmRNSForm 8.3 - Assura Group Limited Replacement
23rd May 20133:05 pmRNSForm 8.3 - Assura Group Ltd
23rd May 20133:02 pmRNSForm 8.3 - Medicx Fund Ltd
23rd May 201311:07 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20139:10 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20138:53 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20138:22 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.